Navigation Links
Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market
Date:5/26/2009

ket opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Russian Electronics Manufacturing Markets

M3AA-28

    Contact:
    Joanna Lewandowska
    Corporate Communications - Europe
    P: +48 22 390 41 46
    E: joanna.lewandowska@frost.com

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
2. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
3. Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males
4. Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards
5. Frost & Sullivan Applauds SHL Telemedicine for Excellence in Product Innovation
6. Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture
7. Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications
8. Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
9. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
10. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
11. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... culture supplement? InVitria has what scientists have been asking for! ... improves the growth and productivity of CHO cells. Developed for ... animal free, well defined and consistent recombinant CHO supplement. ... ... 16, 2009 -- Scientists working with CHO cells can now ...
(Date:12/16/2009)... its 23rd Annual Technical Conference & Exhibition on March 22-25, 2010 ... impact the separation society and reach out to even more experts ... AFS Annual Technical Conference will be co-located with the 2010 AIChE ... ... December 16, 2009 -- The American Filtration and Separations Society will ...
(Date:12/15/2009)... 15 Repligen Corporation (Nasdaq: RGEN ... $731,000 in research funding to support the ongoing ... the Muscular Dystrophy Association (MDA). This grant ... testing and GMP manufacture of a drug candidate ... MDA not only provides important funding for Repligen,s ...
(Date:12/15/2009)... DIEGO, Dec. 15 Aethlon Medical, Inc. ... Dr. Jeff Schorey and Dr. Wayne Comper ... Exosome Sciences, Inc. (ESI). Both Dr. Schorey and ... field. ESI, a wholly owned subsidiary of Aethlon ... that the Hemopurifier®, a medical device being advanced ...
Breaking Biology Technology:Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5
... announced today that the Company will host an investor ... PM Eastern Time to present an,analysis of the data ... IT-R-006) for the treatment of nasolabial folds, or,wrinkles. On ... results from these two studies, which met all primary ...
... benefits of ACTEMRA for rheumatoid,arthritis -, NUTLEY, ... a,total of 15 abstracts involving its investigational rheumatoid ... presentation,at the 2008 American College of Rheumatology (ACR) ... in San Francisco. These,studies evaluate ACTEMRA, a novel ...
... Ventures for Global Health to Work with Industry ... BIO Ventures for Global,Health (BVGH) today announced ... (FDA) release of Draft Guidance for Industry on ... is designed to,encourage industry investment in the development ...
Other Biology Technology:Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies 2ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 2ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 3ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 4FDA Issues Draft Guidance on Priority Review Vouchers 2
(Date:12/16/2009)... DC US Secretary of Energy Steven Chu announced ... for their outstanding contributions in research and development supporting ... six winners named today will receive a gold medal, ... honored at a ceremony in Washington, DC early next ... the national, economic and energy security of the United ...
(Date:12/16/2009)... get psyched up for contests, but when these rituals ... down before and during events, they could be causing ... for the symptoms of an injury, not the injury ... focuses on musculoskeletal health and sports medicine. "They may ... certain level, but pain occurs for a reason. It ...
(Date:12/16/2009)... Medicine researcher will lead the coordinating center for a ... field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., ... the National Heart, Lung and Blood Institute (NHLBI) to ... which will be called the NHLBI Progenitor Cell Biology ... $30 million grant over seven years. , ...
Breaking Biology News(10 mins):Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2NSAIDs: Take 'em early and often when competing? Think again 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 1Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 2Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 3Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 4Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 5Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 6Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 7Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 8Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 9Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 10Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 11Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 12Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 13ETC Biomedical Announces Chamber Sale in India 13344 1ETC Biomedical Announces Chamber Sale in India 13344 2ETC Biomedical Announces Chamber Sale in India 13344 3ETC Biomedical Announces Chamber Sale in India 13344 4OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 1OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 2OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 3
... at Washington University in St. Louis and Arizona State University have ... by making an even rarer form of chlorophyll, chlorophyll d. Chlorophyll ... to the naked eye. , ... with virtually no other plant or bacterium in the world for ...
... of the most important metabolic processes in our bodies, ... intermediates have been produced in multigram quantitieswith one exception, ... University of Leipzig have finally done it. As they ... combination of one biotechnological and one chemical step, starts ...
... with diabetes, cardiac problems, kidney disorders or high blood ... technology. The new "smart" holograms, which can detect ... much simpler, cheaper and more reliable, write Chris Lowe ... hologram is a recording of an optical interference pattern ...
Other Biology News:Bacterium sequenced makes rare form of chlorophyll 2Bacterium sequenced makes rare form of chlorophyll 3Kilogram quantities at last! 2'Smart' holograms help patients help themselves 2